multi-epitope folate receptor alpha-loaded dendritic cell vaccine
Biologicalexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2014 (NCT02111941)
Timeline
Indications
Approved for
Mechanism of action
- Tumor antigensImmunity, active
immunity, active - tumor antigens
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- multi-epitope folate receptor alpha-loaded dendritic cell vaccine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06639074 | Phase 2 | Nov 12, 2024 | Mayo Clinic |
| NCT05920798 | Phase 1/Phase 2 (Phase 2) | Sep 28, 2023 | Mayo Clinic |
| NCT02111941 | N/A | Apr 1, 2014 | Mayo Clinic, National Cancer Institute (NCI) |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Mayo Clinic | Academic/Hospital | 3 | 3 | 2 | 2014 |
| National Cancer Institute (NCI) | Government | 1 | 0 | 1 | 2014 |
2 organizations
Page 1 / 1